Mechanism of Action of GLP-1 agonists GLP-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors comprise two drug categories routinely utilized in the clinical setting
You log your progress, track your doses, request refills, and message your care team about side effects or dosing questions
Schedule your consultation with Newport Beach UC today and begin your path to healthier, lasting weight loss.
After crunching the data, they discovered that participants who used GLP-1 medications had an 81 percent higher relative risk of developing issues with their sense of smell, and a 52 percent higher risk of developing problems with their sense of taste compared to participants who took other diabetes medications
GLP-1 receptor agonists are generally well tolerated, but gastrointestinal side effects are common, particularly when initiating treatment or increasing doses
Restrictions apply